2023 ATS vs ESICM Guidelines for ARDS: How They Differ
ATS breaks with allies, recommends steroids for all ARDS patients
Note: PulmCCM has no affiliation with ATS, ESICM, SCCM or any other professional society.
Back in 2017, the American Thoracic Society, the European Society of Intensive Care Medicine, and the Society of Critical Care Medicine together issued a clinical practice guideline for the management of acute respiratory distress syndrome (ARDS).
That consensus seems to have frayed over the intervening 7 years. ATS and ESICM each separately issued its own updated ARDS guideline in 2023, and SCCM did not lend its name to either. The dueling guidelines conflict in parts, reflecting the fundamental ontological confusion and challenges to effective research on the amorphous syndrome that is ARDS.
Backround
ARDS is not a disease, but a syndrome that includes severe acute hypoxemic respiratory failure due to bilateral pulmonary infiltrates that are not due to cardiogenic pulmonary edema. A very broad range of conditions can create this syndrome, some of which have little in common, pathophysiologically …
Keep reading with a 7-day free trial
Subscribe to PulmCCM to keep reading this post and get 7 days of free access to the full post archives.